News

January 18, 2014 – CBS Minnesota – Student Donates Kidney To Minneapolis Cop – by Holly Wagner
http://minnesota.cbslocal.com/2014/01/18/mpls-cop-35-undergoes-kidney-transplant/

January 17, 2014 – Scientific American – New Genetic Clue to Lupus Is Found: A newly discovered immune-system molecule may work against therapies targeting autoimmune disease – By Jenni Laidman
http://www.scientificamerican.com/article.cfm?id=new-genetic-clue-to-lupus-found

January 15, 2014 – Your Houston News – The Perfect Match: Husband plans to donate kidney to wife – by Jennifer Summer
http://www.yourhoustonnews.com/tomball/living/the-perfect-match-husband-plans-to-donate-kidney-to-wife/article_305e40e0-7e56-11e3-acaf-001a4bcf887a.html?mode=story

January 14, 2014 – Chicago Sun: Lake County Sun Times – Wadsworth woman suffering from lupus takes dialysis machine on world travels – by Frank Abderholden
http://newssun.suntimes.com/news/24960624-418/wadsworth-woman-suffering-from-lupus-takes-dialysis-machine-on-world-travels.html

December 31, 2013 – Huffington Post: Latino Voices – Selena Gomez’s Lupus News Shines Light On Disease Among Hispanics – by Hope Gillette
http://www.huffingtonpost.com/2013/12/31/selena-gomez-lupus-news-_n_4523915.html

Jul 24, 2013 – Reuters, LONDON – British watchdog rejects GSK’s lupus drug again – Reporting by Paul Sandle; editing by Tom Pfeif
http://www.reuters.com/article/2013/07/24/us-gsk-benlysta-idUSBRE96N0C220130724

August 16, 2012 – CNN Health – Olympic Soccer Player Shannon Boxx’s Battle with Lupus – by Jacque Wilson
http://www.cnn.com/2012/08/16/health/olympic-soccer-boxx-lupus/index.html

July 31, 2012 – New York TImes – Olympics – Getting Back Up Is Nothing New for Bronx Gymnast – by Juliet Macur
http://www.nytimes.com/2012/08/01/sports/olympics/bronx-gymnast-puts-rough-day-at-olympics-behind-him.html?_r=1

July 8, 2012 – http://www.sciencedaily.com – What Happens When We Sunburn: Red Is RNA Damage to Skin Cells
http://www.sciencedaily.com/releases/2012/07/120708162244.htm

June 27, 2012 – www.Drugs.com – Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod – by Clinical Trials Newswire
http://www.drugs.com/clinical_trials/anthera-updates-phase-3-plans-following-results-phase-2b-pearl-sc-ranging-study-blisibimod-13950.html

May 27, 2012 – http://www.sciencedaily.com – Discovery Expected to Shift Research Direction in Lupus and Asthma
http://www.sciencedaily.com/releases/2012/05/120527153643.htm

May 10, 2012 – The Sacramento Bee PRNewswire – USNewswire – World Lupus Day Highlights the Impact of Lupus on Millions of People – Press Release by Lupus Foundation of America
http://www.sacbee.com/2012/05/10/4480248/world-lupus-day-highlights-the.html#storylink=cpy

May 7, 2012 – Visalia Times Register – Redwood Golfer Battles Lupus, Life without Kidneys and Makes Name as One of Area’s Top Golfers – by Eric Galvan
http://www.visaliatimesdelta.com/article/20120508/SPORTS/205080312/Redwood-golfer-battles-lupus-life-without-kidneys-makes-name-one-area-s-top-golfers?odyssey=mod|newswell|text|Frontpage|p

May 3, 2012 – U.S. News and World Report Health – New Guidelines Issued for Severe Lupus: More can be done to prevent permanent kidney damage, says American College of Rheumatology – by Serena Gordon, Health Day Reporter
http://health.usnews.com/health-news/news/articles/2012/05/03/new-guidelines-issued-for-severe-lupus

April 26, 2012, London – The Guardian News – Drug Company Attacks NICE for Rejecting New Lupus Treatment: GlaxoSmithKline Criticizes NHS Pharmaceutical Approval Body Over Rejecting Belimumab Drug – by Sarah Boseley, Health Editor
http://www.guardian.co.uk/business/2012/apr/27/drug-company-nice-lupus-reject?newsfeed=true

April 25, 2012, Hayward, CA – Wall Street Journal Market Watch – Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study – Press Release by Anthera Pharmaceuticals, Inc.
http://www.marketwatch.com/story/anthera-announces-the-completion-of-patient-dosing-in-phase-2b-pearl-sc-study-2012-04-25

January 9, 2012 – Genetic Engineering and  Technology News – FDA in 2011 – “During 2011, FDA approved 35 new medicines. This was, according to the agency, among the highest number of approvals in the past decade, surpassed only by 37 approvals in 2009″…  “Notably, the first new therapy for lupus in 50 years was green-lighted this past year.”  http://www.genengnews.com/gen-polls/fda-in-2011/88/

November 7, 2011 – USA Today, Health Day – Vitamin D vaccine show promise against lupus – by Serena Gorton
http://yourlife.usatoday.com/health/healthcare/studies/story/2011-11-07/Vitamin-D-vaccine-show-promise-against-lupus/51106296/1

November 3, 2011 – Wall Street Journal Market Watch – ImmuPharma in Licensing Talks for Lupus Drug – Phase III Clinical Trials to Begin for Drug Lupuzor
http://www.marketwatch.com/story/immupharma-in-licensing-talks-for-lupus-drug-2011-11-03

November 3, 2011 – Regulatory Affairs News – FDA Grants Approval to ImmuPharma Lupuzor to Begin Phase III Trial
http://regulatoryaffairs.pharmaceutical-business-review.com/news/fda-grants-approval-to-immupharma-lupuzor-to-begin-phase-iii-trial-031111

November 2, 2011 – Reuters – Top UK Court Backs Patent Linked to HGS, GSK Drug – by Ben Hirschler
http://www.reuters.com/article/2011/11/02/us-hgs-patent-idUSTRE7A12PA20111102

October 31, 2011 – EON Enhanced Online News – Lupus Organizations Around the Globe Urge NICE to Provide Coverage for Benlysta – Funding block prevents UK patients from receiving drug
http://eon.businesswire.com/news/eon/20111031006069/en/lupus/benlysta/Lupus-Foundation-of-America

October 25, 2011 – http://www.washingtonpost.com – Human Genome Sciences Reveals Slow But Steady Sales of Lupus Drug – by Steven Overly
Human Genome Sciences Reveals Slow But Steady Sales of Lupus Drug

October 2011 – Arthritis Today – www.arthritistoday.org– Lupus News Headlines
http://www.arthritistoday.org/conditions/more-conditions/lupus-news.php

• ‘Multi-target’ immune therapy improves outcomes of severe lupus nephritis
• Abnormal ‘editing’ of gene messages may be cause of lupus
• Cell signaling glitch leads to lupus progression
• Researchers discover a way to turn off immune system cells
• Scientists find genetic variants that increase lupus risk
• New approach for attacking lupus identified
• Compounds may help doctors detect lupus kidney disease
• CellCept linked to pregnancy loss and birth defects
• Vaccine-like treatment shows promise against lupus
• Researchers may have found a new form of lupus
• Transplant drug may be useful for treating lupus

September 29 2011 – NPSA, UK Department of Health – Rapid deterioration in patients with Systemic Lupus Erythematosus
http://www.nrls.npsa.nhs.uk/resources/?entryid45=132831

September 19, 2011 – Science Daily – www.sciencedaily.com – Components That Keep Immune System in Check Identified
http://www.sciencedaily.com/releases/2011/09/110919113947.htm?…Latest+Science+News%29

July 27, 2011 – S.L.E. Lupus Foundation – www.lupusny.org – Novel Drug Candidate May Block Lupus’ Attack on the Brain
http://www.lupusny.org/news/foundation-news/2011/07/27/novel-drug-candidate-may-block-lupus%E2%80%99-attack-brain

July 25, 2011 – CTV News – Health – Benlysta Approved for Canadians with Lupus, Available in September 2011
http://www.ctv.ca/CTVNews/Health/20110712/lupus-drug-benlysta-medication-110712/

July 14, 2011 – Wall Street Journal – Business – New Lupus Drug Benlysta Gets European Approval
http://online.wsj.com/article/BT-CO-20110714-705503.html

May 10, 2011 – Medical News Today – Julian Lennon Leads World Lupus Day Observance On May 10
http://www.medicalnewstoday.com/releases/224727.php

May 9, 2011 – www.ScienceDaily.com – Systemic Lupus Erythematosus: New Test Could Give SLE Patients a More Tolerable Life – Researchers at Lund University in Sweden are developing a blood bio marker test that may help clarify and speed lupus diagnosis.
http://www.sciencedaily.com/releases/2011/05/110509091418.htm

March 29, 2011 – Los Angeles Times – Lupus complication rates soar in young people – By Shari Roan – Arthritis & Rheumatism reports a study of lupus nephritis end-stage renal disease in young people showing alarming increased incidence between 1995 and 2006, especially in young patients of color.
http://articles.latimes.com/2011/mar/29/news/la-heb-lupus-20110329

March 2011 – Benlysta received FDA approval for treatment of lupus!  Benlysta is one of the new biologic drugs developed by Human Genome Sciences in partnership with GlaxoSmithKline.  Benlysta is the first new drug developed and approved specifically for the treatment of lupus in over 50 years.  The following Google News link yields search results for “Benlysta,” with a wealth of recent articles about this new medicine now approved for lupus patients.
http://news.google.com/news/search?aq=0&pz=1&cf=all&ned=us&hl=en&q=benlysta

March 8, 2011 – FierceBiotech – Confidence grows in mega-blockbuster approval for HGS’s Benlysta – by John Carroll
http://www.fiercebiotech.com/story/confidence-grows-mega-blockbuster-approval-hgss-benlysta/2011-03-08

March 8, 2011 – FierceBiotech – GlaxoSmithKline – The world’s biggest R&D spenders– by John Caroll – “…it’s on the verge of hearing the final word from the FDA on Benlysta, the groundbreaking new lupus drug…”
http://www.fiercebiotech.com/special-reports/worlds-biggest-rd-spenders/glaxosmithkline-worlds-biggest-rd-spenders?utm_medium=rss&utm_source=rss

March 7, 2011 – Medical News Today – Benlysta For Lupus Likely To Be Approved This Thursday, A Potential Blockbuster– by Christian Nordqvist
http://www.medicalnewstoday.com/articles/218427.php

March 7, 2011 – Gazette.Net, Maryland Community News Online – Day of reckoning for HGS? Rockville biotech expects FDA ruling on lupus drug Thursday– by Lindsey Robbins – Approval of first new FDA approved drug for lupus, Benlysta, for marketing in U.S. by Human Genome Sciences and Glaxo-SmithKline is highly anticipated on March 10th.
http://www.gazette.net/stories/03072011/businew173613_32559.php